
    
      To gather evidence documenting the performance and clinical outcomes associated with
      treatment of moderate degenerative lumbar spinal stenosis using the Superion® IDS in patients
      ≥45 years of age suffering from symptoms of neurogenic intermittent claudication secondary to
      a confirmed diagnosis of moderate degenerative lumbar spinal stenosis at one or two
      contiguous levels from L1 to L5.
    
  